Evidence map›Paper›PMID 24747743›Full record

ArticleJournal of visualized experiments : JoVE2014

Consensus brain-derived protein, extraction protocol for the study of human and murine brain proteome using both 2D-DIGE and mini 2DE immunoblotting.

Francisco-Jose Fernandez-Gomez, Fanny Jumeau, Maxime Derisbourg, Sylvie Burnouf, Hélène Tran, Sabiha Eddarkaoui, Hélène Obriot, Virginie Dutoit-Lefevre, Vincent Deramecourt, Valérie Mitchell and 6 more

Abstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Francisco-Jose Fernandez-GomezTeam Alzheimer & Tauopathies, Jean-Pierre Aubert Research Centre, Inserm UMR 837.
Fanny JumeauTeam Alzheimer & Tauopathies, Jean-Pierre Aubert Research Centre, Inserm UMR 837; EA 4308-Department of Reproductive Biology-Spermiology-CECOS, CHRU-Lille.
Maxime DerisbourgTeam Alzheimer & Tauopathies, Jean-Pierre Aubert Research Centre, Inserm UMR 837.
Sylvie BurnoufTeam Alzheimer & Tauopathies, Jean-Pierre Aubert Research Centre, Inserm UMR 837.
Hélène TranTeam Alzheimer & Tauopathies, Jean-Pierre Aubert Research Centre, Inserm UMR 837.
Sabiha EddarkaouiTeam Alzheimer & Tauopathies, Jean-Pierre Aubert Research Centre, Inserm UMR 837.
Hélène ObriotTeam Alzheimer & Tauopathies, Jean-Pierre Aubert Research Centre, Inserm UMR 837.
Virginie Dutoit-LefevreEA2686-Laboratorie d'Immunologie, Faculté de Médecine - Pôle Recherche.
Vincent DeramecourtDepartment of Neurology, CHRU-Lille.
Valérie MitchellEA 4308-Department of Reproductive Biology-Spermiology-CECOS, CHRU-Lille.
Didier LefrancEA2686-Laboratorie d'Immunologie, Faculté de Médecine - Pôle Recherche.
Malika HamdaneTeam Alzheimer & Tauopathies, Jean-Pierre Aubert Research Centre, Inserm UMR 837.
David BlumTeam Alzheimer & Tauopathies, Jean-Pierre Aubert Research Centre, Inserm UMR 837.
Luc BuéeTeam Alzheimer & Tauopathies, Jean-Pierre Aubert Research Centre, Inserm UMR 837.
Valérie Buée-ScherrerTeam Alzheimer & Tauopathies, Jean-Pierre Aubert Research Centre, Inserm UMR 837.
Nicolas SergeantTeam Alzheimer & Tauopathies, Jean-Pierre Aubert Research Centre, Inserm UMR 837; nicolas.sergeant@inserm.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Two-dimensional gel electrophoresis (2DE) is a powerful tool to uncover proteome modifications potentially related to different physiological or pathological conditions. Basically, this technique is based on the separation of proteins according to their isoelectric point in a first step, and secondly according to their molecular weights by SDS polyacrylamide gel electrophoresis (SDS-PAGE). In this report an optimized sample preparation protocol for little amount of human post-mortem and mouse brain tissue is described. This method enables to perform both two-dimensional fluorescence difference gel electrophoresis (2D-DIGE) and mini 2DE immunoblotting. The combination of these approaches allows one to not only find new proteins and/or protein modifications in their expression thanks to its compatibility with mass spectrometry detection, but also a new insight into markers validation. Thus, mini-2DE coupled to western blotting permits to identify and validate post-translational modifications, proteins catabolism and provides a qualitative comparison among different conditions and/or treatments. Herein, we provide a method to study components of protein aggregates found in AD and Lewy body dementia such as the amyloid-beta peptide and the alpha-synuclein. Our method can thus be adapted for the analysis of the proteome and insoluble proteins extract from human brain tissue and mice models too. In parallel, it may provide useful information for the study of molecular and cellular pathways involved in neurodegenerative diseases as well as potential novel biomarkers and therapeutic targets.

Indexed as

AnimalsBrainBrain ChemistryCarbocyaninesFluorescent DyesHumansImmunoblottingMiceNerve Tissue ProteinsProteomeTwo-Dimensional Difference Gel ElectrophoresisCarbocyaninesFluorescent DyesNerve Tissue ProteinsProteome

Identifiers

PMID24747743
PMCPMC4166172

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.